PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
24929615-7	2014	In vitro and in vivo experiments demonstrate that ePDA coating functionalized with vascular endothelial growth factor can greatly enhance the desired cellular responses of endothelial cells and prevent the neointima formation after stent implantation.	epda	50-54	vascular endothelial growth factor A	Homo sapiens	83-117
31540502-7	2019	EPDA suppressed the production of monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in both cell lines, and nitric oxide (NO), and macrophage-inflammatory protein-3alpha (MIP3A) in RAW 264.7 macrophages.	epda	0-4	C-C motif chemokine ligand 2	Homo sapiens	34-68
31540502-7	2019	EPDA suppressed the production of monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in both cell lines, and nitric oxide (NO), and macrophage-inflammatory protein-3alpha (MIP3A) in RAW 264.7 macrophages.	epda	0-4	C-C motif chemokine ligand 2	Homo sapiens	70-75
31540502-7	2019	EPDA suppressed the production of monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in both cell lines, and nitric oxide (NO), and macrophage-inflammatory protein-3alpha (MIP3A) in RAW 264.7 macrophages.	epda	0-4	interleukin 6	Homo sapiens	82-95
31540502-7	2019	EPDA suppressed the production of monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in both cell lines, and nitric oxide (NO), and macrophage-inflammatory protein-3alpha (MIP3A) in RAW 264.7 macrophages.	epda	0-4	interleukin 6	Homo sapiens	97-101
31540502-7	2019	EPDA suppressed the production of monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in both cell lines, and nitric oxide (NO), and macrophage-inflammatory protein-3alpha (MIP3A) in RAW 264.7 macrophages.	epda	0-4	C-C motif chemokine ligand 20	Homo sapiens	190-195